-+ 0.00%
-+ 0.00%
-+ 0.00%

Eton Pharma names Judy Matthews CFO, succeeding James Gruber

PUBT·04/16/2026 10:50:19
Listen to the news
Eton Pharma names Judy Matthews CFO, succeeding James Gruber
  • Eton Pharmaceuticals named Judith “Judy” M. Matthews executive vice president, accounting and finance.
  • Matthews will become chief financial officer effective June 1, 2026.
  • Current CFO James Gruber will step down May 31, 2026 as part of a planned succession.
  • Gruber will move to a six-month consulting role following his departure from the CFO post.
  • Matthews previously served as CFO of Iterum Therapeutics from 2015 to 2026.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Eton Pharmaceuticals Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202604160650PRIMZONEFULLFEED9690839) on April 16, 2026, and is solely responsible for the information contained therein.